AUSTIN, Texas--(BUSINESS WIRE)--VMD Sciences, LLC, a pioneering company dedicated to accelerating biomedical innovation for pets, veterinarians, and pet owners, today announces the launch of its Expanded Access Programs (EAPs) for pets and livestock. In collaboration with community veterinarians and animal medicine developers, VMD Sciences aims to address unmet medical needs by providing access to groundbreaking, life-saving treatments.
Introducing animal Expanded Access Programs (EAPs)
VMD Sciences’ animal Expanded Access Programs (EAPs) offer veterinarians and their patients access to cutting-edge treatment options that are often unavailable through standard channels. The company’s commitment to supporting responsible extra-label drug use unlocks the potential of advanced therapies to tackle the toughest veterinary medical challenges facing animals today. Through these Expanded Access Programs, VMD Sciences helps ensure safe and compliant access to life-saving treatments that were previously unavailable. By working closely with veterinarians, the company aims to create new opportunities for improved health of pets and livestock.
A Response to Unmet Needs
“In today's world, the internet and online communities provide pet owners with a wealth of information about global medicines and their potential impact on animal diseases,” said Richard Falcha, President of VMD Sciences. “Unfortunately, some pet owners may turn to unlicensed or unethical sources in desperation, often without involving their veterinarians. Our mission is to provide safe, ethical, and compliant access to global veterinary medicines by collaborating closely with community veterinarians and veterinary pharmaceutical manufacturers. We assist with necessary regulatory filings to enable adherence to established global guidelines.”
Understanding Expanded Access Programs
Expanded Access Programs (EAPs), also known as Managed Access or “Compassionate Use” programs, have been widely utilized in human medicine to grant patients access to unlicensed therapies that address unmet medical needs through regulatory pathways. VMD Sciences is proud to be the first to broadly introduce these programs to the veterinary sector, providing new hope for pets when traditional treatments are no longer viable or available.
“We are thrilled to embark on this new venture in support of pets, veterinarians, and pet owners,” added Falcha. “Our leadership team brings over 100 years of diverse, global human health experience to meet this pressing need. By combining our expertise with top veterinary advisors and animal-focused pharmaceutical and biotechnology companies we aim to safely accelerate the development and accessibility of life-saving pet medicines. This initiative holds the potential to enhance both animal and human well-being through translational medicine.”
VMD Sciences operates through two core functions to assist pets and vets while advancing science:
- Ethical Drug Sourcing: The company supports ethical and legal sourcing of global drugs from territories where they are licensed and supplies them to domestic regions where they are not yet approved.
- Community Veterinarian Scientific Engagement: The company supports its expanding global network of community veterinarians by providing clinical study opportunities, AI-driven software, and logistical support for potential participation in companion animal clinical trials.
VMD Sciences has developed a robust global network for approved drug distribution. Treating veterinarians can initiate unsolicited product inquiries directly through the company’s website at vmdsciences.com, creating a seamless process for obtaining life-saving treatments for animals.
About VMD Sciences, LLC
Veterinariae Medicinae Doctoris: VMD Sciences’ mission is to safely accelerate biomedical innovation for the benefit of pets, vets, and pet owners through direct scientific partnership with community veterinarians who “…have been an overlooked component of the physician-scientist workforce”, according to the NIH Physician-Scientist Workforce Working Group Report. The VMD Sciences Community Veterinarian Network provides members access to promising global medicines and allows them opportunities to provide clinical trials as potential care for animals in need.
